Drug Database
Back to search

Denmark· DK-28104491409

Aivlosin

A tylvalosiini product containing tylvalosintartrat, registered in Denmark by ECO Animal Health Europe Ltd.. The same ATC class is registered in 2 of our 19 countries.

ATC QJ01FA92

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedAivlosinATCQJ01FA92REGISTER NO.DK-28104491409PACKS LISTED1CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tylvalosintartratAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tylvalosintartrat is registered in 2 of 19 countries.

Countries holding a registration under ATC QJ01FA92 (tylvalosiini), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 1 of them publish a price we can compare per daily dose
Search tylvalosintartrat products by name

Tylvalosintartrat · ATC QJ01FA92

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Tylvalosintartrat
Manufacturer
ECO Animal Health Europe Ltd.
Country
Denmark (DK)
ATC code
QJ01FA92
ATC class
Tylvalosiini
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28104491409

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QJ01FA92

Tylvalosiini, as other registers publish it.

All tylvalosintartrat products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d489fb4d-b051-4144-9967-a5518b292fce
GET /v1/drugs/d489fb4d-b051-4144-9967-a5518b292fce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "oralt pulver",
  "source": "dkma",
  "strength": "42,5 mg/g",
  "auth_role": "MOD",
  "dk_drugid": "28104491409",
  "substance": "Tylvalosintartrat",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "40161"
}
API referenceMCP serverPlans

See everything about tylvalosintartrat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console